BRIEF published on 07/31/2025 at 09:05, 4 months 4 days ago Novem Group S.A. to Present Q1 2025/26 Results on 7 August 2025 Conference Call Investor Relations Webcast Novem Group S.A. Q1 2025/26 Results
PRESS RELEASE published on 07/31/2025 at 09:00, 4 months 4 days ago Novem Group S.A.: Invitation to the Q1 2025/26 results presentation on 7 August 2025 Novem Group S.A. invites investors to Q1 2025/26 results presentation on 7th August 2025. CEO & CFO to present first quarter results followed by Q&A session Conference Call Automotive Industry Investor Relations Q1 Results Novem Group
BRIEF published on 06/26/2025 at 09:05, 5 months 8 days ago Novem Group S.A. Reports Decreased Revenue for FY 2024/25 Revenue Decline Novem Group S.A. No Dividend Financial Results 2024/25 Refinancing Plans
PRESS RELEASE published on 06/26/2025 at 09:00, 5 months 8 days ago Novem Group S.A. confirms preliminary results for FY 2024/25 Novem Group S.A. confirms FY 2024/25 results: Revenue €541.5M (-14.8%), Adj. EBIT €48.9M (-29.1%). No dividend proposed. Read more at www.novem.com Financial Results Dividend Proposal Revenue Decline Novem Group S.A. FY 2024/25
BRIEF published on 06/16/2025 at 17:50, 5 months 18 days ago Novem Group S.A. Proposes Dividend Suspension Amid Market Challenges Annual General Meeting Market Challenges Dividend Suspension Novem Group US Tariff
PRESS RELEASE published on 06/16/2025 at 17:45, 5 months 18 days ago EQS-Adhoc: Novem Group S.A.: Suspension of dividend Novem Group S.A. announces suspension of dividend for fiscal year 2024/25 due to market uncertainties and US tariff discussions Novem Group S.A. Dividend Suspension Market Uncertainties Financial Year 2024/25 US Tariff Discussions
BRIEF published on 05/28/2025 at 09:05, 6 months 7 days ago Novem Group S.A. Faces Challenging Market in 2024/25 Financial Results Market Challenges Order Intake Revenue Decline Novem Group
PRESS RELEASE published on 05/28/2025 at 09:00, 6 months 7 days ago Novem Group S.A.: Preliminary results 2024/25 defined by unfavourable market development Novem Group S.A. reports Preliminary Results 2024/25 with revenue of €541.5 million, down 14.8% from FY 2023/24. Market challenges due to weak demand and volatilities around US tariffs Revenue Market Challenges Preliminary Results Novem Group S.A. 2024/25
BRIEF published on 05/21/2025 at 09:05, 6 months 14 days ago Novem Group S.A.: Upcoming FY 2024/25 Results Presentation Conference Call Investor Relations Preliminary Results Novem Group S.A. FY 2024/25
PRESS RELEASE published on 05/21/2025 at 09:00, 6 months 14 days ago Novem Group S.A.: Invitation to the preliminary FY 2024/25 results presentation on 28 May 2025 Novem Group S.A. invites investors to the preliminary FY 2024/25 results presentation on 28 May 2025. CEOs to present followed by Q&A. Webcast available Investors Preliminary Results Conference Novem Group S.A. FY 2024/25
Published on 12/05/2025 at 02:35, 4 hours 15 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 50 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 45 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 50 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 20 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 59 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 25 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 35 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 40 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 50 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 5 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 6 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 49 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
